1.
Marocco A, Stanisic S, Fanelli F, Damele F, Colivicchi F. Alirocumab in the management of primary hypercholesterolaemia or mixed dyslipidaemia: A budget impact analysis – Italian perspective. Grhta [Internet]. 2018 Jul. 16 [cited 2024 Apr. 23];5(1). Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/438